The present invention particularly relates to synthesizing photo-initiators having poly-oligo-silsesquioxane (POSS) structure and realizing photo-polymerization by using these photo-initiators and simultaneous and in-situ synthesis of Ag nano-particles in polymer matrix comprising POSS structure and obtaining wrinkled surfaces as a result of self-arranging thereof.

The invention relates to a silane of the formula (1),

Si(R.sup.1).sub.m(R.sup.2).sub.n(R.sup.3).sub.4-(m+n)  (1)

as defined herein, where the silane has at least one group of the general formula (3):

##STR00001##

as defined herein, to a method for preparing the silane, and to curable compositions, containing the silane and at least one polyorganosiloxane.

An aqueous solution composition containing a co-hydrolysate or a co-hydrolytic condensate of an organosilicon compound of formula (1) and an organosilicon compound of formula (2), or both the co-hydrolysate and the co-hydrolytic condensate:

##STR00001##

wherein R.sup.1 and R.sup.2 are each independently an alkyl group having 1 to 10 carbon atoms or an aryl group having 6 to 10 carbon atoms, R.sup.3 is an alkyl group having 12 to 24 carbon atoms, R.sup.4 and R.sup.5 are each independently an alkyl group having 1 to 6 carbon atoms, X is a halogen atom, m is an integer of 1 to 20, and n is an integer of 1 to 3.

An aqueous solution composition containing a hydrolysate or a hydrolytic condensate of an organosilicon compound of formula (1), or both the hydrolysate and the hydrolytic condensate:

##STR00001##

wherein R.sup.1 and R.sup.2 are each independently an alkyl group having 1 to 10 carbon atoms or an aryl group having 6 to 10 carbon atoms, R.sup.3 is an alkyl group having 12 to 24 carbon atoms, R.sup.4 and R.sup.5 are each independently an alkyl group having 1 to 6 carbon atoms, X is a halogen atom, m is an integer of 4 to 20, and n is an integer of 1 to 3.

An aqueous solution composition containing a co-hydrolysate or a co-hydrolytic condensate of an organosilicon compound of formula (1) and an organosilicon compound of formula (2), or both the co-hydrolysate and the co-hydrolytic condensate: ##STR00001##
wherein R.sup.1 and R.sup.2 are each independently an alkyl group having 1 to 10 carbon atoms or an aryl group having 6 to 10 carbon atoms, R.sup.3 is an alkyl group having 12 to 24 carbon atoms, R.sup.4 and R.sup.5 are each independently an alkyl group having 1 to 6 carbon atoms, X is a halogen atom, m is an integer of 1 to 20, and n is an integer of 1 to 3.

The present invention relates to macrocyclic compounds and compositions containing said compounds acting as kinase inhibitors, in particular as inhibitors of RIP2-kinase, and/or mutants thereof, for use in the diagnosis, prevention and/or treatment of RIP2-kinase associated diseases. Moreover, the present invention provides methods of using said compounds, for instance as a medicine or diagnostic agent.

A photochemical method for chemical modification of a hydrophilic material to provide the surface of the material with hydrophobic properties. The method comprises functionalizing the surface to provide an amine group thereon, and then functionalizing the surface photo-catalytically to provide perfluoroalkanamide thereon. Alternatively, the method comprises reacting a silane moiety functional group on the surface of the material with a perfluoroalkylhalide in the presence of a photo-catalyst and light.

The present invention relates to a non-aqueous electrolyte for a lithium secondary battery and a lithium secondary battery comprising same. The non-aqueous electrolyte comprises: a non-aqueous organic solvent; a lithium salt; a first additive containing at least one compound among compounds represented by chemical formulas 1 to 4; and a second additive containing at least one compound among compounds represented by chemical formula 5 or 6.

A method for the preparation of isocyanates in which: (i) a first organosilicon compound having at least one silicon atom Si.sup.1 and a unit of formula G-I bound thereto

##STR00001##

is converted to a third organosilicon compound having a unit of formula G-II

##STR00002##

by silylation of the NH group of the unit of formula G-I with a second organosilicon compound having one silicon atom Si.sup.2; and (ii) the third organosilicon compound is reacted to an isocyanate by thermolysis, whereby the unit of formula G-II is converted to an isocyanate group.

A compound represented by the general Formula (I) below, or a salt or solvate thereof, which is useful as an ALK inhibitor, and is useful for prophylaxis or treatment of a disease accompanied by abnormality in ALK, for example, cancer, cancer metastasis, depression or cognitive function disorder:

##STR00001## (meanings of the symbols that are included in the formula are as given in the specification).